What is the official ID of this bill?
The official print number for this legislation is S 1323.
End Drug Price Gouging: Establishing Reference Prices for Federal Health Programs.
This act aims to lower prescription drug prices by setting maximum prices that manufacturers cannot exceed. It applies to drugs purchased under federal health programs like Medicare and Medicaid, as well as for uninsured individuals. The goal is to ensure that medications are more accessible and affordable for all citizens.
Key points
Establishment of maximum prescription drug prices based on prices in other countries or therapeutic value.
Reduction of drug costs for individuals covered by federal health programs (e.g., Medicare, Medicaid, TRICARE, VA, FEHBP, Indian Health Service).
Drug manufacturers will be required to offer drugs at the established reference price to everyone, including uninsured individuals.
Financial penalties for manufacturers who do not comply with the new rules, with collected funds allocated to drug research.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.